The firm's Washington, D.C., office, located just blocks away from the White House on K Street, serves the legal needs of technology, life sciences, and growth enterprises, providing services that emphasize the unique characteristics of the nation's capital.
Our D.C. office represents clients across numerous corporate, IP, regulatory, and litigation areas, including antitrust; appellate; internal and government investigations; export controls and trade; M&A; privacy and cybersecurity; patents, trademarks, and copyrights; fund formation; and IT and life sciences technology transactions.
The clients we represent out of our D.C. office range from early-stage start-ups and late-stage technology and life sciences companies to publicly held entities, as well as their board and management teams. We also represent venture capital and private equity firms, along with other investor institutions. Our clients do business in established technology and life sciences industries, including biotech, communications, computer, global generics, medical devices, and software. Our D.C. attorneys also represent innovators and leaders in the AI, digital health, digital media, energy, fintech, mobility, and social media sectors.
We have an established and growing team of regulatory professionals in our D.C. office, including practitioners focused on antitrust, consumer products, healthcare, privacy, international trade, and other areas. Our team has substantial experience before major federal agencies, including the SEC, DOJ, FDA, FTC, FCC, Department of Commerce, Department of State, and the U.S. PTO.
The antitrust team in our D.C. office advises clients with respect to mergers and acquisitions, criminal and civil investigations by government agencies, antitrust litigation, and issues involving intellectual property, consumer protection, and privacy.
Our D.C. office also has a large number of national security practice attorneys who advise clients on a broad range of FCPA, CFIUS, and export trade matters, including: the applicability of government restrictions and licensing requirements; help companies obtain government approvals; represent clients facing government inquiries and investigations; advise companies on internal and board investigations; and undertake diligence and negotiations in conjunction with investments and mergers and acquisitions.
Our fintech practice--which is anchored in our D.C. office--is at the forefront of the token, coin, and ICO market. We represent companies that raise money through token offerings, and advise companies and others that want to invest in token offerings. In addition, our attorneys advise service providers to companies issuing tokens, and form and advise cryptocurrency funds.
Our corporate experience includes facilitating the formation of technology and growth start-ups; negotiating venture capital financing; advising on complex technology and business transactions, including strategic alliances and joint ventures; preparing companies for initial public offerings, secondary offerings, and mergers and acquisitions; and addressing related tax issues.
Our litigation and counseling practices focus nationally on issues related to antitrust and trade, securities defense, corporate governance, IP, export controls and economic sanctions, and privacy and cybersecurity.
Through the seamless integration of all Wilson Sonsini offices, we leverage the institutional experience and resources of the entire firm to provide high-quality services to clients. Our proprietary collaborative systems give our attorneys immediate access to the firm's collective expertise and knowledge, enabling them to respond quickly with effective solutions for our clients.